GSK vs MSFT · P/E 13, $103.31B cap vs P/E 39, rev $331.84B
GlaxoSmithKline PLC ADR (GSK) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
GSK does not have a complete income-statement cache yet.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the GSK and MSFT stock pages for the full models.
Not investment advice.